Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01904526
What this trial is testing

PK/PD Comparison of Guanfacine ER and IR

Who this might be right for
Smoking
Yale University 5
Early research (Phase 1)Study completedNCT05960240
What this trial is testing

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Who this might be right for
Chronic Hepatitis b
Arbutus Biopharma Corporation 128
Testing effectiveness (Phase 2)Looking for participantsNCT07308548
What this trial is testing

A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)
Hinova Pharmaceuticals Inc. 80
Early research (Phase 1)Study completedNCT04554043
What this trial is testing

The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

Who this might be right for
Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd. 118
Early research (Phase 1)Study completedNCT05897008
What this trial is testing

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Taizhou Mabtech Pharmaceutical Co.,Ltd 114
Not applicableUnknownNCT03557840
What this trial is testing

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients

Who this might be right for
PharmacokineticsAntibacterial AgentsInfections, Bacterial+3 more
Paul M. Tulkens 60
Early research (Phase 1)Study completedNCT01110525
What this trial is testing

A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

Who this might be right for
Oral Contraceptives
AstraZeneca 28
Testing effectiveness (Phase 2)Study completedNCT04074317
What this trial is testing

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Who this might be right for
Diabetes Mellitus, Type 1Insulin-dependent Diabetes Mellitus
Xeris Pharmaceuticals 18
Not applicableStudy completedNCT06171243
What this trial is testing

PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain.

Who this might be right for
NeuralgiaNeuropathic PainLocal Anesthetic Complication+1 more
Pontificia Universidad Catolica de Chile 20
Early research (Phase 1)Study completedNCT02135640
What this trial is testing

China HVT Safety, PK, PD

Who this might be right for
Osteoporosis
GlaxoSmithKline 64
Early research (Phase 1)Study completedNCT01147588
What this trial is testing

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Who this might be right for
Healthy
AstraZeneca 149
Early research (Phase 1)Study completedNCT01872572
What this trial is testing

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD

Who this might be right for
Healthy Volunteer
Regado Biosciences, Inc. 36
Early research (Phase 1)Ended earlyNCT04941183
What this trial is testing

Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

Who this might be right for
Covid19
Neutrolis 52
Not applicableUnknownNCT01655004
What this trial is testing

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Who this might be right for
Breast Carcinoma
National University Hospital, Singapore 110
Testing effectiveness (Phase 2)Ended earlyNCT03605212
What this trial is testing

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Who this might be right for
Tumor Lysis Syndrome
Menarini Group 30
Large-scale testing (Phase 3)Study completedNCT07015671
What this trial is testing

Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects

Who this might be right for
Bioequivalence Study in Healthy SubjectsPK/PD
Sarfez Pharmaceuticals, Inc. 24
Early research (Phase 1)Ended earlyNCT02058407
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

Who this might be right for
Bronchiectasis
GlaxoSmithKline 33
Early research (Phase 1)UnknownNCT04768699
What this trial is testing

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Early research (Phase 1)Study completedNCT06044467
What this trial is testing

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

Who this might be right for
Nonalcoholic Fatty Liver Disease
ChemomAb Ltd. 16
Early research (Phase 1)UnknownNCT03668509
What this trial is testing

Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Jiangsu HengRui Medicine Co., Ltd. 30
Next Page